Huang‐Ju Tu

537 total citations
25 papers, 403 citations indexed

About

Huang‐Ju Tu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Huang‐Ju Tu has authored 25 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Huang‐Ju Tu's work include Histone Deacetylase Inhibitors Research (4 papers), Cell Adhesion Molecules Research (4 papers) and Down syndrome and intellectual disability research (3 papers). Huang‐Ju Tu is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Cell Adhesion Molecules Research (4 papers) and Down syndrome and intellectual disability research (3 papers). Huang‐Ju Tu collaborates with scholars based in Taiwan, China and United States. Huang‐Ju Tu's co-authors include Shiow‐Lin Pan, Wen Fu, Min‐Wu Chao, Jing‐Ping Liou, Chia‐Ron Yang, Kai‐Cheng Hsu, Rong‐Sen Yang, Houng‐Chi Liou, Tony Eight Lin and Tzu‐Hung Lin and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Advanced Science.

In The Last Decade

Huang‐Ju Tu

23 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huang‐Ju Tu Taiwan	14	252	120	46	35	31	25	403
Mariya Misheva United Kingdom	5	272 1.1×	58 0.5×	48 1.0×	70 2.0×	18 0.6×	7	465
Eva Berent Israel	13	481 1.9×	121 1.0×	43 0.9×	39 1.1×	15 0.5×	19	663
Allison S. Limpert United States	10	287 1.1×	57 0.5×	76 1.7×	53 1.5×	26 0.8×	10	551
Boh-Ram Kim South Korea	13	248 1.0×	63 0.5×	79 1.7×	36 1.0×	20 0.6×	17	345
Yves Cambet Switzerland	9	184 0.7×	49 0.4×	23 0.5×	62 1.8×	89 2.9×	17	368
Jelena Zarić Switzerland	8	162 0.6×	64 0.5×	45 1.0×	33 0.9×	20 0.6×	15	377
Peter Oladimeji United States	13	287 1.1×	148 1.2×	50 1.1×	26 0.7×	10 0.3×	17	519
Daniel LaSala United States	11	202 0.8×	50 0.4×	35 0.8×	38 1.1×	18 0.6×	17	454
Paola Picardi Italy	14	354 1.4×	120 1.0×	161 3.5×	79 2.3×	24 0.8×	16	730

Countries citing papers authored by Huang‐Ju Tu

Since Specialization

Citations

This map shows the geographic impact of Huang‐Ju Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huang‐Ju Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huang‐Ju Tu more than expected).

Fields of papers citing papers by Huang‐Ju Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huang‐Ju Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huang‐Ju Tu. The network helps show where Huang‐Ju Tu may publish in the future.

Co-authorship network of co-authors of Huang‐Ju Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Huang‐Ju Tu. A scholar is included among the top collaborators of Huang‐Ju Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huang‐Ju Tu. Huang‐Ju Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Chunlin, Huang‐Ju Tu, Tony Eight Lin, et al.. (2025). Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure‐Based Virtual Screening. Advanced Science. 12(19). e2416323–e2416323.

Tu, Huang‐Ju, Tony Eight Lin, Zhaoxiang Peng, et al.. (2024). Discovery of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitors using an artificial intelligence model and their effects on tau and tubulin dynamics. Biomedicine & Pharmacotherapy. 181. 117688–117688. 1 indexed citations

Hwang, Tsong‐Long, Huang‐Ju Tu, Tony Eight Lin, et al.. (2024). Identification, biological evaluation, and crystallographic analysis of coumestrol as a novel dual-specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor. International Journal of Biological Macromolecules. 282(Pt 4). 136860–136860.

Wu, Yiwen, Wei‐Chun HuangFu, Tony Eight Lin, et al.. (2023). Identification of selective dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors and their effects on tau and microtubule. International Journal of Biological Macromolecules. 259(Pt 1). 129074–129074. 3 indexed citations

Tu, Huang‐Ju, et al.. (2023). Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity. Journal of Food and Drug Analysis. 31(2). 358–370. 18 indexed citations

Chao, Min‐Wu, Hsueh‐Yun Lee, Yiting Liu, et al.. (2023). In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2166039–2166039. 5 indexed citations

Wu, Yiwen, Min‐Wu Chao, Huang‐Ju Tu, et al.. (2022). O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia. Phytomedicine. 100. 154061–154061. 7 indexed citations

Liu, Yi-Min, Huang‐Ju Tu, Mei-Jung Lai, et al.. (2021). Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo. European Journal of Medicinal Chemistry. 219. 113428–113428. 14 indexed citations

Lin, Tony Eight, Min‐Wu Chao, Wei‐Chun HuangFu, et al.. (2021). Identification and analysis of a selective DYRK1A inhibitor. Biomedicine & Pharmacotherapy. 146. 112580–112580. 11 indexed citations

10.

Chao, Min‐Wu, Huang‐Ju Tu, Liang‐Chieh Chen, et al.. (2021). A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo. Oncogenesis. 10(5). 39–39. 24 indexed citations

11.

Chao, Min‐Wu, Tony Eight Lin, Wei‐Chun HuangFu, et al.. (2020). Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 98–108. 14 indexed citations

12.

Chao, Min‐Wu, Huang‐Ju Tu, Mei-Jung Lai, et al.. (2019). Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Clinical Epigenetics. 11(1). 85–85. 28 indexed citations

13.

Lin, Tony Eight, Wei‐Chun HuangFu, Min‐Wu Chao, et al.. (2018). A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions. Frontiers in Pharmacology. 9. 1379–1379. 31 indexed citations

14.

Liao, Hsiao‐Mei, Chia‐Hsiang Chen, Huang‐Ju Tu, et al.. (2018). Impairment of social behaviors in Arhgef10 knockout mice. Molecular Autism. 9(1). 11–11. 24 indexed citations

15.

Tu, Huang‐Ju, Min‐Wu Chao, Ting-Yi Sung, et al.. (2018). The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells. Clinical Epigenetics. 10(1). 162–162. 25 indexed citations

16.

Lin, Tzu-Hung, et al.. (2017). Inhibition of osteoporosis by the αvβ3 integrin antagonist of rhodostomin variants. European Journal of Pharmacology. 804. 94–101. 24 indexed citations

17.

Hsu, En‐Chi, Samuel K. Kulp, Han-Li Huang, et al.. (2016). Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer. Carcinogenesis. 37(4). 430–442. 20 indexed citations

18.

Hsu, En‐Chi, Samuel K. Kulp, Huang‐Ju Tu, et al.. (2015). Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6–Abundant Breast Cancer Cells by Regulating γ-Secretase–Mediated Notch1 Activation in Caveolae. Neoplasia. 17(6). 497–508. 39 indexed citations

19.

Lin, Tzu‐Hung, Yung‐Cheng Chiu, Chih‐Hsin Tang, et al.. (2014). 5-Lipoxygenase Inhibitors Attenuate TNF-α-Induced Inflammation in Human Synovial Fibroblasts. PLoS ONE. 9(9). e107890–e107890. 55 indexed citations

20.

Tu, Huang‐Ju, Tzu‐Hung Lin, Yung‐Cheng Chiu, et al.. (2012). Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts. Journal of Cellular Physiology. 228(5). 983–990. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact